Oncology Institute (TOI) Preferred Stock Liabilities (2020 - 2021)
Oncology Institute (TOI) posted Preferred Stock Liabilities of $230.0 million for Q3 2021, up 680.44% quarter-over-quarter from $29.5 million in Q2 2021, and up 767.68% year-on-year from $26.5 million in Q3 2020.
Oncology Institute (TOI) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends
Oncology Institute (TOI) has reported Preferred Stock Liabilities for 2 consecutive years, with $230.0 million the latest figure, recorded in Q3 2021.
- Preferred Stock Liabilities for Q3 2021 came in at $230.0 million, up 767.68% year-over-year; the trailing twelve-month figure through Sep 2021 was $230.0 million (up 767.68% YoY), and the FY2020 annual result was $230.0 million, changed N/A from the prior year.
- Preferred Stock Liabilities was $230.0 million for Q3 2021 at Oncology Institute, up from $29.5 million in the prior quarter.
- Over five years, Preferred Stock Liabilities peaked at $230.0 million in Q1 2020 and troughed at $23.3 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 87.94 Bn | 90.32 Bn | 16.26 Bn | - |
| 2 | Chemed | 18.08 Bn | 18.07 Bn | 215.76 Mn | - |
| 3 | Tenet Healthcare | 16.59 Bn | 15.76 Bn | 4.41 Bn | - |
| 4 | Davita | 15.37 Bn | 16.23 Bn | 1.07 Bn | - |
| 5 | Encompass Health | 10.07 Bn | 10.70 Bn | 1.34 Bn | - |
| 6 | Ensign | 9.52 Bn | 8.93 Bn | 293.37 Mn | - |
| 7 | Universal Health Services | 9.19 Bn | 9.15 Bn | 3.21 Bn | - |
| 8 | Pacs | 6.96 Bn | 6.72 Bn | 345.96 Mn | - |
| 9 | Ww International | 6.14 Bn | 5.98 Bn | -149.29 Mn | - |
| 10 | Oncology Institute | 560.93 Mn | 530.65 Mn | 139.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 230.00 Mn |
| Jun 30, 2021 | 29.47 Mn |
| Mar 31, 2021 | 23.35 Mn |
| Dec 31, 2020 | 230.00 Mn |
| Sep 30, 2020 | 26.51 Mn |
| Jun 30, 2020 | 205.91 Mn |
| Mar 13, 2020 | 230.00 Mn |